Assertio Holdings, Inc. · NASDAQ:ASRT
Assertio — Q4 2022 Earnings Presentation
16 slides from Assertio's earnings presentation, Mar 8, 2023
Slide 1: Assertio Holdings, Inc. Q4 2022 Financial Results
Assertio Holdings, Inc. Q4 2022 Financial Results
Slide 2: About This Presentation
About This Presentation Statements in this communication that are not statements of historical fact are forward-looking statements that reflect Assertio's current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in relia
Slide 3: Q4 2022 Financial Results - Overview
Q4 2022 Financial Results -Overview Var Var Var Q4 '22 Var ($ in 000's) Q4 2022 Q3 2022 Q4 vs. Q3 % Q4 2021 vs. '21 % Net Product Sales (GAAP) $ 49,866 $ 34,279 $ 15,587 45% $ 32,152 $ 17,714 55% Adjusted EBITDA (Non-GAAP) 1 $ 33,377 $ 21,442 $ 11,935 56% $ 17,827 $ 15,550 87% Adjusted EPS (Non-GAAP
Slide 4: Q4 2022 Financial Results - SG&A Summary
Q4 2022 Financial Results -SG&A Summary Var Var Var Q4 '22 Var ($ in 000's) Q4 2022 Q3 2022 Q4 vs. Q3 % Q4 2021 vs. '21 % Adjusted SG&A (Non-GAAP) $ 11,122 $ 9,303 $ 1,819 20% $ 10,114 $ 1,008 10% Full Year Full Year Var Var ($ in 000's) 2022 2021 '22 vs. '21 % Adjusted SG&A $ 38,495 $ 48,133 $ (9,6
Slide 5: Q4 2022 Financial Results - Cash Balance & Debt
Q4 2022 Financial Results -Cash Balance & Debt Q4 vs. Q3 21 vs 22 ($ in 000's) Q4 2022 Q3 2022 $ Change % Change Q4 2021 $ Change % Change Cash and cash equivalents $ 64,941 $ 64,826 $ 115 0% $ 36,810 $ 28,131 76% Senior secured debt 1 $ - $ - $ - 0% $ 70,750 $ (70,750) -100% Convertible debt 2 $ 70
Slide 6: 2023 Guidance
2023 Guidance 2023 Full Year Guidance Net Product Sales $150.0 - $160.0 Million Adjusted EBITDA (Non-GAAP) $85.0 - $93.0 Million 2023 Guidance reflects the following factors: • Net Sales: • Cambia loss of exclusivity on January 1, 2023 • Addition of Sympazan (partially offsets Cambia loss of exclusi
Slide 7: Supplemental Information
Supplemental Information /SSSERTIO
Slide 8: Note Regarding Use of GAAP and Non-GAAP Measures
Note Regarding Use of GAAP and Non-GAAP Measures Non-GAAP Financial Measures To supplement the Company’s financial results presented on a U.S. generally accepted accounting principles (“GAAP”) basis, the Company has included information about non-GAAP measures of EBITDA, adjusted EBITDA, adjusted ea
Slide 9: Statements of Comprehensive Income
Statements of Comprehensive Income 9
Slide 10: Balance Sheets
Balance Sheets ASSERTIO HOLDINGS, INC. CONSOLIDATED BALANCE SHEETS (im thousands, except share data) (unaudited) December 31. 2022 zon ASSETS Current assets: Cash and cash equivalents s oaoa 36,810 Accounts receivable, net 45,357 44,361 Inventories, net 13,696 7.489 Prepaid and other current assets
Slide 11: Statements of Cash Flows
Statements of Cash Flows 18,939 7508 3.265 (80,375) 96) (6593) S019 (toz08) 13.236) TESOR (er (27,027) (15,372) (42.673) ast ap 4.268 3,000 (28,099) 10.482) STS cc) 8472) 8.525) ASSSERTIO=
Slide 12: Non-GAAP Adjusted EBITDA Reconciliation
Non-GAAP Adjusted EBITDA Reconciliation For additional information referencing the schedules adjusting items, refer to the quarterly results announcement Form-8K on file with the Securities and Exchange Commission on the date of this presentation. 12
Slide 13: Non-GAAP Adjusted Earnings and EPS Reconciliation
Non-GAAP Adjusted Earnings and EPS Reconciliation For additional information referencing the schedules adjusting items, refer to the quarterly results announcement Form-8K on file with the Securities and Exchange Commission on the date of this presentation. 13
Slide 14: Non-GAAP Adjusted Earnings and EPS Reconciliation
Non-GAAP Adjusted Earnings and EPS Reconciliation For additional information referencing the schedules adjusting items, refer to the quarterly results announcement Form-8K on file with the Securities and Exchange Commission on the date of this presentation. 14
Slide 15: Additional Supplemental Schedules
Additional Supplemental Schedules (in thousands ) (unaudited) Non-GAAP Adjusted SG&A Reconciliation Three Months Ended Three Months Ended Three Months Ended December 31, 2022 S eptember 30, 2022 December 31, 2021 GAAP S G&A $ 13,706 $ 11,900 $ 11,266 Adjustments: Stock-based compensation (2,388) (2,
Slide 16: Investor Contact
Investor Contact Matt Kreps Darrow Associates Investor Relations [email protected]